Co-Diagnostics, Inc. Gains 82.45%
Mon, Jan 27, 2020 at 05:30 PM
Co-Diagnostics, Inc. (CODX:NASDAQ) rocketted at $3.43, a gain of 82.4%. The stock got featured on our News Catalysts scanner on Mon 27 Jan 20 at 09:34 AM in the 'BIOTECH' category. From Fri 03 Jan 20, the stock recorded 42.86% Up Days and 46.67% Green Days
The stock spiked on Thu 23 Jan 20 at $2.8 with a volume of 35M+.
About Co-Diagnostics, Inc. (CODX:NASDAQ)
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
Top 10 Gainers:
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 210.61%
- Lianluo Smart Limited (LLIT:NASDAQ), 152.29%
- NanoViricides, Inc. (NNVC:NYSEMKT), 86.98%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 82.45%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 65.42%
- Miragen Therapeutics, Inc. (MGEN:NASDAQ), 50.52%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 50%
- Vaxart, Inc. (VXRT:NASDAQ), 30%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 28.33%
- Sophiris Bio, Inc. (SPHS:NASDAQ), 27.23%